Skip to main navigation Skip to search Skip to main content

A Fucose-containing Hetero-exopolysaccharide From Levilactobacillus brevis B151 Exhibits Potent Antimicrobial, Antibiofilm, and Antioxidant Activities

  • Manoj Kumar Yadav
  • , Remilyn M. Mendoza
  • , Ji Hoon Song
  • , Robie Vasquez
  • , Jae Seung Lee
  • , Yeong Seo Park
  • , Hyun Dong Paik
  • , In Ho Kim
  • , Dae‑Kyung Kang
  • Dankook University
  • Gachon University

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Exopolysaccharides (EPSs) have recently emerged as significant substances due to their remarkable biological properties. This research aimed to analyze EPS B151 extracted from Levilactobacillus brevis B151 and evaluate its biological activities. EPS B151 was obtained at a yield of 438 mg/L. Structural analysis using the Congo red method and Fourier transform infrared spectroscopy (FTIR) revealed a random coil structure and characteristic typical carbohydrate peaks (O-H, C-H, C = O, and C-O-C), along with a pyranose ring containing both α- and β-glycosidic bonds. Scanning electron microscopy (SEM) revealed a porous, irregular, and loosely compact morphology. High-pressure liquid chromatography (HPLC) analysis indicated that EPS B151 is a heteropolysaccharide composed of mannose, ribose, glucosamine, glucuronic acid, glucose, galactose, and the rare sugar fucose. This unique composition is the first reported for an L. brevis-derived EPS. EPS B151 demonstrated significant antimicrobial activity against Staphylococcus aureus KFRI00188 and Listeria monocytogenes ATCC3596, inhibiting growth and cell viability in a dose-dependent manner, with bactericidal effects confirmed by propidium iodide staining and SEM analysis. It also inhibited biofilm formation (up to 58.09 ± 2.97% for Staph. aureus and 51.53 ± 3.84% for L. monocytogenes) in a dose-dependent manner. Furthermore, EPS B151 demonstrated potent antioxidant activity in multiple in vitro assays, including ABTS•+, DPPH, and OH• radical-scavenging, along with significant reducing power. In cytotoxicity assays, EPS B151 was non-toxic to normal colon cells (CCD-18Co) but showed significant inhibitory effects against colon cancer (Caco-2) and gastric cancer (AGS) cell lines, suggesting its potential anticancer properties. Overall, EPS B151 is a multifunctional bioactive compound with antimicrobial, antibiofilm, antioxidant, and anticancer properties, highlighting its potential as a functional ingredient in the food, biomedical, and pharmaceutical industries.

Original languageEnglish
Pages (from-to)5509-5524
Number of pages16
JournalProbiotics and Antimicrobial Proteins
Volume18
Issue number4
DOIs
StatePublished - May 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antibiofilm activity
  • Antimicrobial activity
  • Antioxidant activity
  • Exopolysaccharide (EPS)
  • Levilactobacillus brevis

Fingerprint

Dive into the research topics of 'A Fucose-containing Hetero-exopolysaccharide From Levilactobacillus brevis B151 Exhibits Potent Antimicrobial, Antibiofilm, and Antioxidant Activities'. Together they form a unique fingerprint.

Cite this